OpenAI Startup Fund and Founders Fund back Coherence Neuro's $45M seed
OpenAI's venture capital arm and Peter Thiel's Founders Fund are investing in Coherence Neuro, a San Francisco startup developing a brain implant to detect and treat cancer, as part of a $45 million seed round, WIRED AI reported. Coherence says it already knows how to detect brain-tumor electrical signals in animals to tell whether cancer is growing, shrinking or recurring, and this summer it briefly tested its implant's recording ability in three people undergoing brain tumor removal at Royal Melbourne Hospital, with the device in place for about 30 minutes as an initial safety check. The company next plans to test recording and stimulation in seven more patients and to use the funding for a clinical trial implanting the device long-term in glioblastoma patients; CEO Ben Woodington said OpenAI will not have access to its brain or other health data under the contracts or arrangements.
WIRED frames the round as reflecting Big Tech's burgeoning interest in brain data, and it is OpenAI's second brain-computer interface investment after its January backing of Merge Labs.
OpenAI’s venture capital arm as well as Peter Thiel’s Founders Fund are investing in Coherence Neuro, a startup developing a brain implant to detect and treat cancer.
The investments are part of a $45 million seed funding round for Coherence and reflect Big Tech’s burgeoning interest in brain data. Coherence’s CEO and cofounder Ben Woodington says there is “growing synergy” between the big AI labs and companies building devices to decode the brain, known as brain-computer interfaces.
“The idea of capturing data to train better models and use it to optimize treatments is going to be super important,” he says. “The AI companies seem to be aligned with this thesis as well—that this novel data source is going to be valuable.”
Woodington says AI is a “perfect use case” for brain-computer interfaces because developers of these devices generate massive datasets that are too large for humans to analyze themselves. AI models can help read raw neural data and link it to actions, such as moving a computer cursor or producing synthesized speech.
In January, OpenAI announced that it was directly investing in a new brain-computer interface company, Merge Labs, cofounded by its billionaire CEO Sam Altman. Merge Labs came out of stealth with $252 million in initial funding to pursue ultrasound technology that can decode information from the brain. At the time, OpenAI said it was funding Merge Labs because of a belief that brain-computer interfaces “will create a natural, human-centered way for anyone to seamlessly interact with AI.” (The name Merge Labs comes from the idea popular in Silicon Valley that humans will eventually merge with machine intelligence.)
#OpenAI#OpenAI Startup Fund#Coherence Neuro#Founders Fund#Merge Labs#Neuralink#CTRL-labs#Royal Melbourne Hospital